These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 6543506)

  • 41. [Nifedipine in the treatment of hypertension].
    Guazzi M
    Rev Esp Cardiol; 1982; 35(5 Suppl 2):II23-5. PubMed ID: 7170405
    [No Abstract]   [Full Text] [Related]  

  • 42. Calcium channel blockers in the treatment of hypertension.
    Raspa RF; Wilson CC
    Am Fam Physician; 1993 Sep; 48(3):461-70. PubMed ID: 8362695
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Introduction: the role of calcium antagonists.
    van Zwieten PA
    J Hypertens Suppl; 1998 Oct; 16(6):S1-2. PubMed ID: 9856376
    [No Abstract]   [Full Text] [Related]  

  • 44. [Choice of a calcium channel blocker].
    Grönhagen-Riska C
    Duodecim; 1997; 113(21):2181-6. PubMed ID: 10892116
    [No Abstract]   [Full Text] [Related]  

  • 45. Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding. Ad Hoc Subcommittee of the Liaison Committee of the World Health Organisation and the International Society of Hypertension.
    Hypertens Res; 1997 Jun; 20(2):61-73. PubMed ID: 9220269
    [No Abstract]   [Full Text] [Related]  

  • 46. Nifedipine.
    Nurs Times; 2005 Jul 19-25; 101(29):31. PubMed ID: 16052940
    [No Abstract]   [Full Text] [Related]  

  • 47. Pharmacomodulation of endothelial dysfunction: clinical relevance.
    Dalal JJ
    Indian Heart J; 1999; 51(3):338-41. PubMed ID: 10624080
    [No Abstract]   [Full Text] [Related]  

  • 48. [Criteria of the clinical application of Ca++ antagonists].
    Kishida H; Saito H; Hayakawa H
    Nihon Rinsho; 1982; 40(11):2477-83. PubMed ID: 6218317
    [No Abstract]   [Full Text] [Related]  

  • 49. Prevalence of coronary calcification in relation to age, gender and risk factor profile in the insight population.
    Motro M; Shemesh J
    Br J Clin Pract Suppl; 1997 Apr; 88():1-5. PubMed ID: 9519500
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adverse reactions to short-acting nifedipine in hypertensive crises.
    Spizzirri F; Rahman R
    Pediatr Nephrol; 1999 May; 13(4):366. PubMed ID: 10454793
    [No Abstract]   [Full Text] [Related]  

  • 51. [Comment on the information by the Federal Drug and Medical Products Institute on "calcium channel blockers of the 1,4-dihydropyridine class"].
    Trenkwalder P
    Internist (Berl); 1995 Jul; 36(7):730-1. PubMed ID: 7672923
    [No Abstract]   [Full Text] [Related]  

  • 52. On a possible role for calcium antagonists in atherosclerosis. A personal view.
    Hugenholtz PG; Lichtlen P; van der Giessen W; Becker AE; Nayler WG; Fleckenstein A; Hülsmann WC
    Eur Heart J; 1986 Jul; 7(7):546-59. PubMed ID: 3530767
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Calcium channel blockers and coronary heart disease.
    Inzitari M; Di Bari M; Marchionni N
    Aging Clin Exp Res; 2005 Aug; 17(4 Suppl):6-15. PubMed ID: 16640169
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dangers, myths, controversy. Sublingual nifedipine for hypertensive crisis.
    Kaufman SE; Schneider EF
    JAAPA; 2000 Mar; 13(3):67-8, 71-4, 80. PubMed ID: 11503405
    [No Abstract]   [Full Text] [Related]  

  • 55. The nifedipine scare in hypertension: fact or fiction.
    Gambhir DS
    Indian Heart J; 1996; 48(3):227-9. PubMed ID: 8755005
    [No Abstract]   [Full Text] [Related]  

  • 56. The use of short acting calcium channel blockers.
    Hassall JJ
    N Z Med J; 1996 Jan; 109(1014):18. PubMed ID: 8628532
    [No Abstract]   [Full Text] [Related]  

  • 57. [ELSA Studies studies progression of atherosclerosis. Calcium antagonist arrests the process more than a beta-blocker].
    Einecke D
    MMW Fortschr Med; 2001 Jul; 143(26-27):6. PubMed ID: 11481923
    [No Abstract]   [Full Text] [Related]  

  • 58. Nifedipine improves coronary and peripheral endothelial function in patients with coronary artery disease: are calcium channel blockers acquitted on the charges?
    Celik T; Kursaklioglu H; Iyisoy A; Yuksel C; Isik E
    Int J Cardiol; 2007 Apr; 116(3):406-7. PubMed ID: 16839624
    [No Abstract]   [Full Text] [Related]  

  • 59. [Calcium antagonists and arterial hypertension].
    Laurent S; Billaud E; Kreft-Jais C
    Therapie; 1993; 48 Spec No():659-64. PubMed ID: 8091351
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Barnidipine, a long-acting slow onset calcium antagonist.
    Korstanje C
    Int J Clin Pract Suppl; 2000 Nov; (114):2-5. PubMed ID: 11221290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.